← Back to screener

Jade Biosciences, Inc. JBIO

Rank #2526 · Nasdaq · $0.7B market cap
⚠ Going-concern flag — the auditor (PricewaterhouseCoopers LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
4.4
P/E
-5.4
P/B
693999.84
ROE
-12741000.0%
Op. Margin
–%
Debt Ratio
11959600%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -5.4x, P/B 693999.84x. Ranks in the top 92% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -12741000.0%. Ranks in the top 100% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 11959600%. Ranks in the top 100% of the universe. Above 200% signals meaningful leverage risk.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Valuation is the relative strength (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2021–$-0.0B$-0.0B$-0.0B–-49
2022–$-0.0B$-0.0B$-0.0B–-22
2023–$-0.1B$-0.1B$0.2B–5
2024–$-0.1B$-0.1B$0.1B–14
2025–$-0.1B$-0.1B$0.0B–11959600

← See the full screener